Status:
TERMINATED
Continuous Intraocular Pressure (IOP) Monitoring in Pigmentary Dispersion Syndrome and Pigmentary Glaucoma Patients
Lead Sponsor:
Sensimed AG
Collaborating Sponsors:
Private practicioner, Dr Sunaric Mégevand
Orasis, AugenZentrum Pajic
Conditions:
Pigmentary Dispersion Syndrome
Pigmentary Glaucoma Patients
Eligibility:
All Genders
18-60 years
Brief Summary
This study monitors the intraocular pressure (IOP) over 4 to 6 hours using the SENSIMED Triggerfish® device and Goldmann Applanation Tonometry (GAT) in pigment dispersion syndrome and pigmentary glauc...
Eligibility Criteria
Inclusion
- Confirmed diagnosis of pigmentary dispersion syndrome or pigmentary glaucoma on both eyes
- IOP of ≥ 15 mmHg
- 18-60 years.
- Patients able to jog continuously for at least 25 minutes
- Phakic eyes
- Patients who accept signing an informed consent approved by the Ethics Committee.
Exclusion
- Pigmentary glaucoma already treated with peripheral laser iridotomy (PLI), argon laser peripheral iridoplasty (ALPI), argon laser trabeculoplasty (ALT) and selective laser trabeculoplasty (SLT) in any eye
- Patients treated with pilocarpine or other mydriatic agent within the last 4 weeks in any eye
- Anti-hypertensive treatment in the 4 weeks preceding the study and throughout the study. Following signature of informed consent, anti-hypertensive treatment will be washed out for 4 weeks prior to study procedures in enrolled patients
- Patients with pseudoexfoliative (PEX) syndrome or PEX glaucoma in any eye
- Patients not able to understand the nature of the research
- Patients under tutorship
- Corneal abnormality
- Subjects with contraindications for wearing contact lenses
- Full frame metal glasses during SENSIMED Triggerfish® monitoring
- History of other ocular surgery except uncomplicated strabismus surgery no later than 3 months prior to study procedures
- Ocular inflammation or infection
- History of cardiac or pulmonary disorder
- Pregnancy and lactation
- Simultaneous participation in other clinical research
Key Trial Info
Start Date :
September 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2011
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT01253109
Start Date
September 1 2010
End Date
November 1 2011
Last Update
January 24 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Private practice - Dr Sunaric Mégevand
Geneva, Switzerland, 1206